Thanks for the above data. I've never known of good sources of data on child-patients with these meds.
I'm finding Lamotrigine possibly being under-utilized.
No labs, no incredible amounts of weight gain, possible iatrogenic weight loss (that many patients welcome)...
Yes there's the Stevens Johnson Syndrome but if the patient takes it right, they'll notice a rash first and stop the med just like you the physician should warn them about.
I've found Lamotrigine a good choice for patients with problems affording medications. Some places sell the 100 mg tabs of it for only about $20 for a month's supply. While Lithium and Carbamazepine are only $4 a month, they also require labwork on the order of costing hundreds of dollars every few months.
Abilify can definitely cause weight gain in adolescents, probably more so then in adults. Regarding efficacy, the jury is still out.
I've noticed in my anectdotal experience that there is a subgroup of patients that oddly gain weight from it. From that experience, and only on adults, I've noticed it being on the order of effifacy as Geodon and Seroquel (that were rated as lower in efficacy in CATIE), but also noticed that there are patients it works well with and those same patients also don't have to suffer from weight gain, sedation, and sexual side effects. In short, if you want to try a med where the patient may have a fair shot of lesser side effects (if any), this is worth a try.
I've also noticed that there's a subgroup of patients that tend to get akithesia and EPS quite strongly with Abilify.
I asked a prominent researcher from the NIMH if they planned on doing a new CATIE study involving the newer atypicals that weren't included in the original CATIE. He told me that unfortuantely that was extremely unlikely to happen.